Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Life Science

• Publication date

  2001-02-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(01)00946-8PMID 11263672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test.

  2000cited by this paper
• Isolation, Purity Analysis and Stability of Hyperforin as a Standard Material from Hypericum perforatum L.

  1999cited by this paper
• Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex

  1999cited by this paper
• Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.

  1999cited by this paper
• Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat.

  1999cited by this paper
• Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.

  1999cited by this paper
• Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism.

  1999cited by this paper
• Hypericum for depression. An update of the clinical evidence.

  1999cited by this paper
• Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers

  1998cited by this paper
• Hyperforin as a possible antidepressant component of hypericum extracts.

  1998cited by this paper
• Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility

  1998cited by this paper
• Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.

  1998cited by this paper
• Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)

  1998cited by this paper
• St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.

  1998cited by this paper
• Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.

  1998cited by this paper
• Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.

  1998cited by this paper
• Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an Overview

  1997cited by this paper
• In Vitro Receptor Binding and Enzyme Inhibition by Hypericum perforatum Extract

  1997cited by this paper
• Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.

  1997cited by this paper
• LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical Trial

  1997cited by this paper
• Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

  1997cited by this paper
• Effects of Long-Term Administration of Hypericum Extracts on the Affinity and Density of the Central Serotonergic 5-HT1 A and 5-HT2 A Receptors

  1997cited by this paper
• Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.

  1997cited by this paper
• Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.

  1996cited by this paper
• The value of psychiatric treatment: its efficacy in severe mental disorders.

  1993cited by this paper
• Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

  1993cited by this paper
• Structure and function of the sodium and potassium-coupled glutamate transporter from rat brain.

  1993cited by this paper
• Adhyperforin: A Homologue of Hyperforin from Hypericum perforatum

  1992cited by this paper
• Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935

  1992cited by this paper
• Inhibition of monoamine oxidase by hypericin.

  1984cited by this paper

• Convergent gene clusters underpin hyperforin biosynthesis in St John's wort.

  2022cites this paper
• Label-Free LC/HRMS-Based Enzymatic Activity Assay for the Detection of DDC, MAO and COMT Inhibitors in Natural Extracts

  2021cites this paper
• Chinese Pharmacopoeia Revisited: A Review of Anti-Depression Herbal Sources

  2021cites this paper
• Chronic SJW pretreatment in the regulation of Cerebral Serotonergic and Behavioral Activity

  2020cites this paper
• Exploring feature selection of St John's wort grown under different light spectra using 1 H-NMR spectroscopy.

  2020cites this paper
• Protective Role of St. John’s Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies

  2020cites this paper
• Opportunities in Novel Psychotropic Drug Design from Natural Compounds

  2019cites this paper
• Clinical relevance of St. John's wort drug interactions revisited

  2019cites this paper
• Natural Products from Single Plants as Sleep Aids: A Systematic Review

  2018cites this paper
• Phytochemical and pharmacological studyof Hypericum triquetrifolium TURRA

  2018cites this paper
• Neuropharmacology of Genus Hypericum : Hypericin and Hyperforin

  2018cites this paper
• Biosynthetic and Total Synthetic Approaches for (+)-Hyperforin

  2018cites this paper
• Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action

  2018cites this paper
• Biotechnological production of hyperforin for pharmaceutical formulation

  2017cites this paper
• A current update on phytochemistry, pharmacology and herb–drug interactions of Hypericum perforatum

  2017cites this paper
• Recent Advances Regarding Constituents and Bioactivities of Plants from the Genus Hypericum

  2015cites this paper
• Lc-Dad-Ms-Assisted Quantification Of Marker Compounds In Hypericum Perforatum L. (St. John's Wort) And Its Antioxidant Activity

  2015cites this paper
• Natural products of relevance in the prevention and supportive treatment of depression.

  2015cites this paper
• Chemistry and Biology of the Polycyclic Polyprenylated Acylphloroglucinol Hyperforin

  2014cites this paper
• Investigation of the elemental profiles of Hypericum perforatum as used in herbal remedies

  2014cites this paper
• Acylphloroglucinol derivatives from Hypericum andinum: antidepressant-like activity of andinin A.

  2014cites this paper
• Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L.

  2014cites this paper
• Preclinical data supporting/refuting the use of Hypericum perforatum in the treatment of depression.

  2013cites this paper
• Assessment of antimicrobial and antiprotozoal activity of the olive oil macerate samples of Hypericum perforatum and their LC-DAD-MS analyses.

  2013cites this paper
• Effect of Hypericum perforatum Extract in an Experimental Model of Binge Eating in Female Rats

  2012cites this paper
• Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.

  2012cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMÁCIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS Avaliação do mecanismo de ação antidepressiva e estudo da toxicidade oral aguda e de doses repetidas de Hypericum polyanthemum em camundongos

  2012cites this paper
• Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.

  2011cites this paper
• Pharmacotherapeutics of Echinacea purpurea: Gardening shelf to Clinic

  2011cites this paper
• Hyperforin promotes mitochondrial function and development of oligodendrocytes

  2011cites this paper
• Biosynthesis of hypericins and hyperforins in Hypericum perforatum L. (St. John’s wort) – precursors and genes involved

  2010cites this paper
• Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).

  2010cites this paper
• Hyperforin in St . John ’ s Wort ’ s Central Effects : What is the Mechanism of Action ?

  2010cites this paper
• Factors Affecting Polyphenol Biosynthesis in Wild and Field Grown St. John’s Wort (Hypericum perforatum L. Hypericaceae/Guttiferae)

  2009cites this paper
• St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects.

  2009cites this paper
• Chapter 4 St . John ’ s Wort : Quality Issues and Active Compounds

  2009cites this paper
• Avaliação pré-clínica da atividade do tipo antidepressiva de quatro preparações comerciais de Hypericum perforatum e a sua correlação com os teores de hiperforina

  2009cites this paper
• Herbal toxicity.

  2009cites this paper
• Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels

  2008cites this paper
• Assessment of the content of phenolics and antioxidant actions of the Rubiaceae, Ebenaceae, Celastraceae, Erythroxylaceae and Sterculaceae families of Mauritian endemic plants.

  2008cites this paper
• Molecular mechanisms underlying St. John's wort drug interactions.

  2008cites this paper
• St. John's wort: Role of active compounds for its mechanism of action and efficacy

  2007cites this paper
• Antioxidant activity of cichoric acid and alkamides from Echinacea purpurea, alone and in combination

  2007cites this paper
• Biosynthesis of hyperforin and adhyperforin from amino acid precursors in shoot cultures of Hypericum perforatum.

  2007cites this paper
• St. John’s Wort

  2007cites this paper
• Antidepressant-like effect of Cecropia glazioui Sneth and its constituents - in vivo and in vitro characterization of the underlying mechanism.

  2007cites this paper
• Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake.

  2007cites this paper
• Dietary Supplements of Plant Origin: A Nutrition and Health Approach

  2007cites this paper
• Hyperforin.

  2006cites this paper
• Role of hyperforin in the pharmacological activities of St. John's Wort.

  2006cites this paper
• Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation.

  2006cites this paper
• Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant‐like activity

  2006cites this paper
• Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin.

  2006cites this paper
• Hypericum Perforatum: A ‘Modern’ Herbal Antidepressant

  2006cites this paper
• Analysis of selected constituents in methanolic extracts of Hypericum perforatum collected in different localities by capillary ITP‐CZE

  2006cites this paper
• Polycyclic polyprenylated acylphloroglucinols.

  2006cites this paper
• Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips

  2006cites this paper
• Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach

  2006cites this paper
• Ex situ studies on chemical variability of St.John's wort [Hypericum perforatum L.] growing wild in Lithuania

  2006cites this paper
• Análise química e taxonômica de espécies de hypericum e avaliação da atividade antiangiogênica

  2006cites this paper
• Estudo da constituição química de hypericum carinatum (guttiferae) e avaliação da atividade inseticida de hypericum polyanthemum

  2006cites this paper
• Avaliação do efeito de um extrato lipofílico de Hypericum caprifoliatum Cham.& Schltdl sobre os níveis cerebrais de dopamina e seus metabólitos através de microdiálise cerebral em ratos conscientes

  2006cites this paper
• Hyperforin activates nonselective cation channels (NSCCs)

  2005cites this paper
• Pharmacokinetics and biopharmaceuticals

  2005cites this paper
• A survey on the Hypericum genus : secondary metabolites and bioactivity

  2005cites this paper
• Effects on transmitter uptake and their cellular and molecular basis

  2005cites this paper
• The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake.

  2005cites this paper
• Antidepressant-like components of Hypericum perforatum extracts: an overview of their pharmacokinetics and metabolism.

  2005cites this paper
• Biosynthesis of the hyperforin skeleton in Hypericum calycinum cell cultures.

  2005cites this paper
• High-performance liquid chromatography measurement of hyperforin and its reduced derivatives in rodent plasma.

  2005cites this paper
• [Discussion on clinical efficacy of Hypericum perforatum for depression abroad].

  2004cites this paper
• Complementary alternative medicine and nuclear medicine

  2004cites this paper
• Prenylated benzophenones and xanthones from Hypericum scabrum.

  2004cites this paper
• Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoamines.

  2004cites this paper
• Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro.

  2004cites this paper
• Metal content monitoring in Hypericum perforatum pharmaceutical derivatives by atomic absorption and emission spectrometry.

  2004cites this paper
• Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.

  2004cites this paper
• St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro

  2004cites this paper
• Air/light-free hyphenated extraction/analysis system: supercritical fluid extraction on-line coupled with liquid chromatography-UV absorbance/electrospray mass spectrometry for the determination of hyperforin and its degradation products in Hypericum pertoratum.

  2004cites this paper
• Hypericum perforatum, a source of neuroactive lead structures.

  2003cites this paper
• Plant derivatives in the treatment of alcohol dependency.

  2003cites this paper
• Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St. John's wort treatment

  2003cites this paper
• Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.

  2003cites this paper
• Hyperforin-Containing Extracts of St John's Wort Fail to Alter Gene Transcription in Brain Areas Involved in HPA Axis Control in a Long-Term Treatment Regimen in Rats

  2003cites this paper
• Current St John's wort research from mode of action to clinical efficacy.

  2003cites this paper
• The content of hypericins and phloroglucinols in Hypericum perforatum L. seedlings at early stage of development

  2003cites this paper
• Clinic at the Health Food Store? Employee Recommendations and Product Analysis

  2003cites this paper
• Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry.

  2003cites this paper
• Mechanism of Action of St John’s Wort in Depression

  2003cites this paper
• Inhibition of vesicular uptake of monoamines by hyperforin.

  2002cites this paper
• St. John's wort and depression: efficacy, safety and tolerability-an update.

  2002cites this paper
• Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts

  2002cites this paper
• St . John ’ s Wort Extract Induces CYP 3 A and CYP 2 E 1 in the Swiss Webster Mouse

  2002cites this paper
• Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase.

  2002cites this paper
• Challenges and opportunities confronting the botanical dietary supplement industry.

  2002cites this paper
• Blockade of gamma-aminobutyric acid receptors does not modify the inhibiton of ethanol intake induced by Hypericum perforatum in rats.

  2002cites this paper
• St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse.

  2002cites this paper
• Separation of hypericins and hyperforins in extracts of Hypericum perforatum L. using non-aqueous capillary electrophoresis with reversed electro-osmotic flow.

  2002cites this paper
• On-line coupling of capillary isotachophoresis and capillary zone electrophoresis for the determination of flavonoids in methanolic extracts of Hypericum perforatum leaves or flowers.

  2002cites this paper
• Is St John's wort a ‘Prozac-like’ herbal antidepressant?

  2001cites this paper